Growth Metrics

Quest Diagnostics (DGX) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 0.21.

  • Quest Diagnostics' FCF Payout Ratio fell 3678.26% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 2206.97%. This contributed to the annual value of 0.36 for FY2024, which is 19.55% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' FCF Payout Ratio is 0.21, which was down 3678.26% from 0.21 recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' FCF Payout Ratio ranged from a high of 1.58 in Q1 2024 and a low of 2.24 during Q1 2023
  • Moreover, its 5-year median value for FCF Payout Ratio was 0.23 (2021), whereas its average is 0.21.
  • Within the past 5 years, the most significant YoY rise in Quest Diagnostics' FCF Payout Ratio was 28612.37% (2023), while the steepest drop was 136363.64% (2023).
  • Quest Diagnostics' FCF Payout Ratio (Quarter) stood at 0.23 in 2021, then soared by 75.53% to 0.4 in 2022, then tumbled by 56.16% to 0.18 in 2023, then soared by 40.1% to 0.25 in 2024, then decreased by 13.77% to 0.21 in 2025.
  • Its FCF Payout Ratio stands at 0.21 for Q3 2025, versus 0.21 for Q2 2025 and 0.43 for Q1 2025.